Skip to main content Skip to secondary navigation


Main content start

Our translational medicine laboratory received a significant boost thanks to a recent FDA contract grant in September 2023. This award provides full funding for the next three years. Additionally, a collaboration with insurance giant Nippon Life, secured in November 2023, further strengthens our financial resources.

These funds will enable us to embark on a wider range of projects focused on leveraging AI technologies to improve care management and optimize resource utilization. The lab has a proven track record of securing funding, having previously received grants from Stanford, the NIH, and the AHA. Looking ahead, we plan to pursue additional grants from organizations like the NIH, NSF, DOE, and FDA in upcoming application cycles.